The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ventolin 500 micrograms/ml Solution for Injection



GlaxoSmithKline (Ireland) LimitedPA1077/049/001

Main Information

Trade NameVentolin 500 micrograms/ml Solution for Injection
Active SubstancesSalbutamol
Dosage FormSolution for injection
Licence HolderGlaxoSmithKline (Ireland) Limited
Licence NumberPA1077/049/001

Group Information

ATC CodeR03AC Selective beta-2-adrenoreceptor agonists
R03AC02 salbutamol

Status

License statusAuthorised
Licence Issued10/11/1975
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back